Psychiatrist

Amanda Rose Wallace, MD

525 E 68th St, New York, New York, 10065

About Amanda Rose Wallace

Amanda Rose Wallace is a psychiatrist based in New York, New York who is specialized in Psychiatry. Active license number of Amanda Rose Wallace is 297971 for Psychiatry in New York. Her current practice location is 525 E 68th St, New York. Patients can contact her at 212-746-1641. Amanda Rose Wallace, MD, specializes in Psychiatry and her NPI number (Unique professional ID assigned by NPPES) is 1649665977.

Amanda Rose Wallace specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

Practice Information

Amanda Rose Wallace's specialty, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.

Provider Name Amanda Rose Wallace
Specialization Psychiatry
Credentials MD
Gender Female
Practice Address: 525 E 68th St,
New York, NY - 10065

Professional Identification Codes

NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to healthcare providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.

NPI Number1649665977
NPI Enumeration Date: 03 Apr, 2015
NPI Last Update On: 11 Sep, 2019

Medical Licenses:

Healthcare professionals can hold one or more medical licenses for different specialties in the same state or different states. Related medical licenses for Amanda Rose Wallace are as mentioned below.

License NumberSpecializationStateStatus
297971Psychiatry New YorkPrimary
144544Psychiatry CaliforniaSecondary

Mailing Address

Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned Practice address.

Amanda Rose Wallace
525 E 68th St., Box 140
New York, NY - 10065-4870

Book an Appointment with Amanda Rose Wallace

To schedule an appointment, contact Amanda Rose Wallace at 525 E 68th St, New York, New York or call the phone number listed below.

Book an Appointment

Frequently Asked Questions

Below are some commonly asked questions about Amanda Rose Wallace:

Amanda Rose Wallace is a psychiatrist specializing in Psychiatry. She specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

Yes, Amanda Rose Wallace is currently accepting new patients. To schedule an appointment, contact the office directly and schedule an appointment.
*Availability may change. Please contact the office directly to ask about appointments.

Amanda Rose Wallace practices at 525 E 68th St, New York, New York, 10065.

To schedule an appointment with Amanda Rose Wallace, please contact the office at 212-746-1641.

Reviews & Feedback

Have you visited Amanda Rose Wallace? Share your experience to help others looking for a psychiatrist in New York, NY.

Read Reviews / Give Feedback
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 September, 2026.